101 related articles for article (PubMed ID: 25298182)
21. Vaccination-challenge interval markedly influences protection provided by Rispens CVI988 vaccine against very virulent Marek's disease virus challenge.
Islam T; Walkden Brown SW; Renz KG; Fakhrul Islam AF; Ralapanawe S
Avian Pathol; 2013 Dec; 42(6):516-26. PubMed ID: 24098951
[TBL] [Abstract][Full Text] [Related]
22. [Isolation and characterization of a non-pathogenic Marek's disease virus with a naturally inserted REV LTR sequence].
Chen R; Luo Q; Guo' K; Liu Z; Li H; Wang J
Wei Sheng Wu Xue Bao; 2014 Jun; 54(6):670-8. PubMed ID: 25272816
[TBL] [Abstract][Full Text] [Related]
23. Sequence determination of a mildly virulent strain (CU-2) of Gallid herpesvirus type 2 using 454 pyrosequencing.
Spatz SJ; Rue CA
Virus Genes; 2008 Jun; 36(3):479-89. PubMed ID: 18351449
[TBL] [Abstract][Full Text] [Related]
24. Marek's disease: Genetic regulation of gallid herpesvirus 2 infection and latency.
Gennart I; Coupeau D; Pejaković S; Laurent S; Rasschaert D; Muylkens B
Vet J; 2015 Sep; 205(3):339-48. PubMed ID: 26067852
[TBL] [Abstract][Full Text] [Related]
25. Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus.
Karpathy RC; Firth GA; Tannock GA
Aust Vet J; 2002; 80(1-2):61-6. PubMed ID: 12180882
[TBL] [Abstract][Full Text] [Related]
26. Genetic evolution of Gallid herpesvirus 2 isolated in China.
Lv H; Zhang Y; Sun G; Bao K; Gao Y; Qi X; Cui H; Wang Y; Li K; Gao L; Pan Q; Wang X; Liu C
Infect Genet Evol; 2017 Jul; 51():263-274. PubMed ID: 27112385
[TBL] [Abstract][Full Text] [Related]
27. Comparative full-length sequence analysis of Marek's disease virus vaccine strain 814.
Zhang F; Liu CJ; Zhang YP; Li ZJ; Liu AL; Yan FH; Cong F; Cheng Y
Arch Virol; 2012 Jan; 157(1):177-83. PubMed ID: 21984218
[TBL] [Abstract][Full Text] [Related]
28. Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model.
Baigent SJ; Smith LP; Currie RJ; Nair VK
Avian Pathol; 2007 Dec; 36(6):467-74. PubMed ID: 17994325
[TBL] [Abstract][Full Text] [Related]
29. Molecular and pathogenicity characterization of Gallid herpesvirus 2 newly isolated in China from 2009 to 2013.
Zhang YP; Lv HC; Bao KY; Gao YL; Gao HL; le Qi X; Cui HY; Wang YQ; Li K; Gao L; Wang XM; Liu CJ
Virus Genes; 2016 Feb; 52(1):51-60. PubMed ID: 26611441
[TBL] [Abstract][Full Text] [Related]
30. Replication kinetics and shedding of very virulent Marek's disease virus and vaccinal Rispens/CVI988 virus during single and mixed infections varying in order and interval between infections.
Islam T; Walkden-Brown SW; Renz KG; Islam AF; Ralapanawe S
Vet Microbiol; 2014 Oct; 173(3-4):208-23. PubMed ID: 25213229
[TBL] [Abstract][Full Text] [Related]
31. Serotype specificity of B-haplotype influence on the relative efficacy of Marek's disease vaccines.
Bacon LD; Witter RL
Avian Dis; 1994; 38(1):65-71. PubMed ID: 8002902
[TBL] [Abstract][Full Text] [Related]
32. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM
Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987
[TBL] [Abstract][Full Text] [Related]
33. Influence of vaccination with CVI988/Rispens on load and replication of a very virulent Marek's disease virus strain in feathers of chickens.
Haq K; Fear T; Ibraheem A; Abdul-Careem MF; Sharif S
Avian Pathol; 2012; 41(1):69-75. PubMed ID: 22845323
[TBL] [Abstract][Full Text] [Related]
34. Early posthatch protection against Marek's disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine.
Zhang Y; Sharma JM
Avian Dis; 2001; 45(3):639-45. PubMed ID: 11569737
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation the immuno-protective effect of an infectious clone of meq- deleted Marek's disease virus].
Li Y; Kang M; Su S; Ding J; Cui Z; Zhu H
Wei Sheng Wu Xue Bao; 2010 Jul; 50(7):942-8. PubMed ID: 20815243
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of the meq gene of Marek's disease viruses detected in unvaccinated backyard chickens reveals the circulation of low- and high-virulence strains.
Mescolini G; Lupini C; Felice V; Guerrini A; Silveira F; Cecchinato M; Catelli E
Poult Sci; 2019 Aug; 98(8):3130-3137. PubMed ID: 30850833
[TBL] [Abstract][Full Text] [Related]
37. A recombinant fowlpox virus vaccine expressing glycoprotein B gene from CVI988/Rispens strain of MDV: protection studies in different chickens.
Liu X; Peng D; Wu X; Xing L; Zhang R
Acta Virol; 1999; 43(2-3):201-4. PubMed ID: 10696446
[TBL] [Abstract][Full Text] [Related]
38. Marek's disease viruses circulating in commercial poultry in Italy in the years 2015-2018 are closely related by their meq gene phylogeny.
Mescolini G; Lupini C; Davidson I; Massi P; Tosi G; Catelli E
Transbound Emerg Dis; 2020 Jan; 67(1):98-107. PubMed ID: 31411371
[TBL] [Abstract][Full Text] [Related]
39. Isolation and purification of Gallid herpesvirus 2 strains currently distributed in Japan.
Machida Y; Murata S; Matsuyama-Kato A; Isezaki M; Taneno A; Sakai E; Konnai S; Ohashi K
J Vet Med Sci; 2017 Jan; 79(1):115-122. PubMed ID: 27725354
[TBL] [Abstract][Full Text] [Related]
40. Sequence determination of variable regions within the genomes of gallid herpesvirus-2 pathotypes.
Spatz SJ; Silva RF
Arch Virol; 2007; 152(9):1665-78. PubMed ID: 17557133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
